Showing results (181-190 of 392) with videos related to

Sort By:
Pageof 40
Blood|October 13, 2005
Fludarabine plus cyclophosphamide versus fludarabine alone in first-line therapy of younger patients with chronic lymphocytic leukemiaBarbara F Eichhorst, Raymonde Busch, Georg Hopfinger, et al.
Haematologica|November 2, 2020
Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG)Sonia Jaramillo, Andreas Agathangelidis, Christof Schneider, et al.
Cellular & Molecular Biology Letters|May 7, 2026
CRISPR and compound screens in a novel ex vivo tissue model identify DDR1 and ETA as regulators of cancer cell invasionJunnan Liu, Wencheng Jiang, Xue Wang, et al.
Cancer Medicine|December 1, 2023
Regional outcome disparities in German head and neck cancer patients: Shorter survival in Eastern GermanyJulius M Vahl, Gabriele Nagel, Tsima Abou Kors, et al.
Aging Cell|February 8, 2026
Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent FibroblastsAlbert Kallon Koroma, Karmveer Singh, Yongfang Wang, et al.
Leukemia|May 6, 2022
The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemiaLisa Rusyn, Sebastian Reinartz, Anastasia Nikiforov, et al.
British Journal of Haematology|November 22, 2018
Outcome of patients aged 80 years or older treated for chronic lymphocytic leukaemiaOthman Al-Sawaf, Jasmin Bahlo, Sandra Robrecht, et al.
Leukemia|August 21, 2021
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patientsSelcen Öztürk, Yashna Paul, Saira Afzal, et al.
Blood|April 20, 2004
Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regionsHolger Kohlhammer, Carsten Schwaenen, Swen Wessendorf, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 4, 2006
Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantationThorsten Zenz, Richard F Schlenk, Gerhard Glatting, et al.
Pageof 40